Background {#Sec1}
==========

Coronary artery disease (CAD) is the most common cardiovascular disease caused by coronary stenosis, spasm or occlusion. Despite widespread use of established medical therapies, CAD remains the leading cause of mortality in women in most developed countries. It is estimated that up to 23.6 million people will succumb to cardiovascular disease by 2030 \[[@CR1]\] because of increasing obesity, whose rate has doubled between 1980 and 2008, and is expected to further increase.

Epidemiological studies have shown that males are more affected by accelerated atherosclerotic cardiovascular disease (CVD) compared with women \[[@CR2]--[@CR4]\]. The discovery of sex-dependent disparities in the development of cardiovascular disease has prompted studies aiming at further understanding of ischemic heart disease in women along the continuum of clinical care. In general, the first CVD event occurs 9 years earlier in males compared with females, although this gap narrows with age \[[@CR5]\]. The reasons for gender differences in CVD are complex and include clinical risk profile, downstream effects of sex hormones and behavior, although they cannot in many ways fully account for outcome disparity \[[@CR6]--[@CR8]\].

Although women are thought to have a greater symptom burden and a higher rate of functional disability but a lower prevalence of obstructive CAD \[[@CR9]--[@CR11]\], plaque morphology and composition data comparing coronary artery disease in women and men are scarce. A few pathological studies suggested that gender may confer differences in coronary plaque characteristics \[[@CR12]\]. These findings indicate a potentially distinct form of pathophysiology for atherosclerosis in women. The underlying pathophysiology is probably related to the plaque type. Studies have reported that ruptured and/or vulnerable plaques exist at nonculprit lesions, as well as in culprit segments in acute coronary syndrome (ACS) patients \[[@CR13]--[@CR15]\]. Moreover, patients with ACS that underwent percutaneous coronary intervention were shown to have similar recurrent adverse cardiovascular event rates in culprit and nonculprit lesions (12.9% versus 11.6% during a 3-year follow-up period) \[[@CR16]\]. However, the characteristics of nonculprit plaques in CAD patients have not been clearly defined. Therefore, to compare coronary nonculprit plaque characteristics in CAD patients in vivo between genders may help understand the underlying pathophysiology of CAD and prevent recurrent cardiovascular events.

Optical coherence tomography (OCT) is an intravascular imaging tool that allows visualization of coronary arteries with high resolution \[[@CR17]\]. OCT provides detailed structural information on intracoronary pathology, including plaque morphology, components, and microstructures associated with instability in vivo. The OCT characteristics for various components of atheromatous plaques have been validated in a histology-controlled study \[[@CR18]\] As such, the technique provides a unique platform to evaluate the association of gender with coronary artery pathology. The aim of this study was therefore to evaluate differences in OCT-estimated characteristics of nonculprit plaques between women and men with CAD.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

Patient selection for the present study is summarized in Fig. [1](#Fig1){ref-type="fig"}. A total of 556 patients between January 2013 and December 2014 were retrospectively assessed, including 181 who had undergone OCT imaging. Only patients with complete information about clinical history, laboratory data, physical status, and sufficient image quality for all 3 vessels were selected. Therefore, 135 subjects with complete demographic data and sufficient 3-vessel OCT images were included. Plaques were identified with diameter stenosis \> 30% by OCT compared with the reference vessel \[[@CR19]\]. Patients without nonculprit plaques were also excluded. Based on angiograms, any plaque treated by percutaneous coronary intervention was excluded. Other exclusion criteria included myocardial infarction, cardiogenic shock, left main coronary artery disease, serious hepatic or renal dysfunction, massive thrombus and poor OCT image quality. Because it would be potentially difficult to acquire and interpret OCT-obtained images, patients with PCI, severe left ventricular dysfunction, or coronary artery bypass grafting were also excluded. Therefore, the final analysis included the remaining 103 subjects, with 187 nonculprit plaques.Fig. 1The patient count breakdown outline

This study was approved by the Ethics Review Committee of the Second Affiliated Hospital of Harbin Medical University, Harbin, China. All patients provided written informed consent.

OCT image acquisition {#Sec4}
---------------------

All patients received standard antiplatelet and antithrombotic therapy with a loading dose of oral aspirin (300 mg) and ticagrelor (180 mg). Images were acquired on a commercially available frequency-domain OCT (FD-OCT) (C7XR system, Saint Jude Medical, Westford, MA, US). Intracoronary OCT examination was performed as previously described \[[@CR20]\]. Briefly, a 2.7 F OCT imaging catheter (Dragonfly, LightLab Imaging Inc., Westford, MA) was advanced distal to the lesion, and automatic pullback was started as soon as the blood is cleared. All images were de-identified and digitally stored.

Angiographic analysis {#Sec5}
---------------------

Coronary angiography was performed on a Cardiovascular Angiography Analysis System (CAAS 5.10, Pie Medical Imaging B.V., Maastricht, the Netherlands). The parameters of quantitative coronary angiography (QCA) included lesion length, reference vessel diameter (RVD), minimal lumen diameter (MLD) and diameter stenosis (DS). RVD was defined as the average diameter of the distal and proximal reference diameters. DS was derived as follow: DS = (RVD - MLD)/RVD × 100%.

OCT image analysis {#Sec6}
------------------

Nonculprit plaques with diameter stenosis 20 to 70% on quantitative coronary angiography and culprit plaques undergoing percutaneous coronary intervention (PCI) were analyzed. A nonculprit plaque was defined as coronary artery stenosis with diameter stenosis 20 to 70%, for which PCI has not been performed. The acquired OCT images were analyzed by two investigators blinded to clinical presentations. In case of discordance between the two investigators, a consensus reading was obtained. Plaque characteristics were defined by previously validated criteria \[[@CR21], [@CR22]\]. A lipid-rich plaque was defined as one with lipid involving \> 90° of the vessel wall circumference (lipid arc) \[[@CR17]\]. For lipid-rich plaques, the lipid arc, lipid-core length, thinnest fibrous cap thickness (FCT) were determined, as well as the presence of thin-cap fibroatheroma (TCFA), macrophage accumulation, cholesterol crystals, and microvessels. Lipid-core length was defined as the length of plaque with \> 90° of lipid arc and measured on the longitudinal view. The lipid index, defined as the mean lipid arc multiplied by lipid-core length \[[@CR20]\], was also assessed. The fibrous cap thickness (FCT) of each lipid-rich plaque was measured 3 times at its thinnest part, and averaged. A thin cap fibroatheroma (TCFA) was defined as a lipid-rich plaque with a maximum lipid arc \> 90° and a FCT \< 65 μm \[[@CR23]\] (Fig. [2](#Fig2){ref-type="fig"}a). A microvessel was defined as a signal-poor void without connection to the lumen, recognized on ≥3 consecutive cross-sectional images \[[@CR22], [@CR24]\] (Fig. [2](#Fig2){ref-type="fig"}b). Cholesterol crystals were defined as thin, linear regions of high intensity within the plaque \[[@CR22], [@CR25]\] (Fig. [2](#Fig2){ref-type="fig"}c). Macrophage accumulation on OCT images was identified by increased signal intensity within the plaque, accompanied by heterogeneous backward shadows \[[@CR26], [@CR27]\] (Fig. [2](#Fig2){ref-type="fig"}d). Calcification was also recorded when an area with low backscatter and a sharp border was identified inside the plaque \[[@CR22]\] (Fig. [2](#Fig2){ref-type="fig"}e). Plaque disruption was defined as a discontinuity of the fibrous cap with communication between the vessel lumen and the cavity \[[@CR23]\] (Fig. [2](#Fig2){ref-type="fig"}f). Thrombus was defined as a mass (diameter ≥ 250 μm) attached to the luminal surface or floating within the lumen \[[@CR17], [@CR22], [@CR23]\] (Fig. [2](#Fig2){ref-type="fig"}g and h).Fig. 2Representative optical coherence tomography images. **a** TCFA, defined as a lipid-rich plaque with a fibrous cap thickness \< 65 μm (arrows). **b** Microvessels are represented by black holes within the plaque (arrow). **c** Cholesterol crystals are reflected by thin, linear regions of high intensity within the plaque (arrows). **d** Macrophage accumulation on OCT images, defined as increased signal intensity within the fibrous cap, accompanied by heterogeneous backward shadows (arrows). **e** Calcification is reflected by an area with low backscatter signal and a sharp border (arrows). **f** Plaque disruption showing discontinuity of the fibrous cap. **g** White (platelet-rich) thrombus is represented by low and homogeneous backscattering with low signal attenuation (arrow). **h** Red (red blood cell-rich) thrombus is represented by high backscattering with high attenuation (arrows)

Statistical analysis {#Sec7}
--------------------

All statistical analyses were performed with SPSS version 22.0 (IBM Corp., Armonk, NY). Categorical data were presented as number (percent) and compared by the χ^2^ or Fisher exact test, depending on data type. Continuous variables are mean ± standard deviation (SD); if necessary, median and 25th to 75th percentile were also presented. Differences between continuous variables were assessed by unpaired Student t test or Mann--Whitney test. *P* \< 0.05 was considered statistically significant. For comparisons between groups, analysis was performed by means of the generalized estimating equations approach to take into account the within-subject correlation attributable to multiple plaques analyzed within a single subject. Univariate and multivariate linear regression analyses were performed to assess the relationship between lipid index and other factors.

Results {#Sec8}
=======

Patients and angiographic features {#Sec9}
----------------------------------

The baseline characteristics of the included patients are listed in Table [1](#Tab1){ref-type="table"}. The 103 patients included 26 (25.2%) women and 77 (74.8%) men. Female patients were significantly older (mean age, 70.8 ± 7.3 vs 60.8 ± 9.8 years, respectively; *P* \< 0.001) and had higher levels of low-density lipoprotein cholesterol (92.2 ± 27.0 vs 79.4 ± 27.6 mg/dL; *P* = 0.043) compared with men. Male patients were more likely to be current smokers (29.9% of men vs 3.8% of women; *P* = 0.007). No significant differences were found in the incidence rates of hypertension, diabetes mellitus, and drug use prior to admission between women and men.Table 1Baseline clinical characteristicsVariableMen, *n* = 77Women, *n* = 26*P* Value Age, y60.8 ± 9.870.8 ± 7.3\< 0.001Risk factors Hypertension, n (%)47 (61.4)13 (50.0)0.324 Dyslipidemia, n (%)39 (50.6)15 (57.7)0.534 Diabetes mellitus, n (%)31 (40.3)10 (38.5)0.871 Current smoker, n (%)23 (29.9)1 (3.8)0.007Medications before admission Aspirin, n (%)63 (81.8)22 (84.6)0.745 Statins, n (%)57 (74.0)21 (80.8)0.488 β-Blockers, n (%)29 (37.7)10 (38.5)0.942 ACE inhibitors, n (%)19 (24.7)7 (26.9)0.820Biochemistry data TC, mg/dL151.6 ± 37.5166.6 ± 37.50.082 LDL-C, mg/dL79.4 ± 27.692.2 ± 27.00.043 HDL-C, mg/dL40.2 ± 7.643.1 ± 12.60.164 TG, mg/dL178.4 ± 167.7149.9 ± 65.20.402 HbA~1c~, %6.6 ± 1.36.9 ± 1.50.415 hs-CRP, mg/L3.0 ± 2.81.6 ± 1.30.082 Creatinine, mg/L0.9 ± 0.20.8 ± 0.20.018 Fasting glucose, mg/L116.1 ± 41.8139.1 ± 68.00.113*Abbreviations: HbA*~*1c*~ glycated hemoglobin, *HDL-C* high-density lipoprotein cholesterol, *hs-CRP* high-sensitivity C-reactive protein, *IQR* interquartile range, *LDL-C* low-density lipoprotein cholesterol, *TC* total cholesterol, *TG* triglycerides. Data are n (%) or mean ± SD

Angiographic data are listed in Table [2](#Tab2){ref-type="table"}. Reference vessel diameter (RVD), minimum lumen diameter (MLD) and diameter stenosis (DS) were not significantly different between male and female patients; however, lesion length was greater in men compared with women (9.4 ± 4.5 vs 7.3 ± 4.3, *P* = 0.024).Table 2Angiographic findingsVariableMen, *n* = 135Women, *n* = 52*P* ValuePlaque location, n (%)0.739 LAD, n (%)45 (33.3)15 (28.8) LCX, n (%)37 (27.4)17 (32.7) RCA, n (%)53 (39.3)20 (38.5) Multivessel disease, n (%)38 (49.4)13 (50.0)0.954QCA findings lesion length, mm9.4 ± 4.57.3 ± 4.30.024 RVD, mm3.0 ± 0.53.0 ± 0.60.640 MLD, mm1.9 ± 0.41.9 ± 0.40.645 Diameter stenosis, %37.3 ± 7.636.9 ± 7.70.750*Abbreviations: LAD* left anterior descending artery, *LCX* left circumflex artery, *RCA* right coronary artery; *QCA, MLD* minimum lumen diameter, *RVD* reference vessel diameter, Data are n (%) or mean ± SD

OCT findings {#Sec10}
------------

Quantitative and qualitative features of plaque morphologies by OCT are summarized in Table [3](#Tab3){ref-type="table"}. No significant differences were found in minimum lumen area and mean reference vessel area between the two groups. Lipid-core length (9.54 ± 4.5 mm vs 7.3 ± 2.7 mm, *P* = 0.024) and lipid index (1615.1 ± 893.8 mm^2^ vs 1237.8 ± 859.8 mm^2^, *P* = 0.035) were significantly greater in men compared with women. There were no significant differences in FCT (men, 89.2 ± 34.9 μm; women, 93.4 ± 48.2 μm; *P* = 0.597) and TCFA prevalence (men, 37.7%; women, 46.2%; *P* = 0.444). The prevalence rates of other microstructures, such as disruption, calcification, microvessels, or cholesterol crystals, were not significantly different between genders.Table 3Optical coherence tomography (OCT) findingsVariablesMen, *n* = 77Women, *n* = 26*P* ValueMLA, mm^2^3.1 ± 1.33.1 ± 1.30.746Mean RVA, mm^2^7.1 ± 2.57.3 ± 2.70.684Stenosis area, %42.6 ± 11.042.9 ± 10.80.880Lipid-rich plaque Lipid-rich, n (%)87 (64.4)35 (67.3)0.713 Maximum lipid arc224.1 ± 63.6210.0 ± 58.50.259 Lipid length, mm9.4 ± 4.57.3 ± 4.30.024 Lipid index1615.1 ± 893.81237.8 ± 859.80.035 FCT, μm89.2 ± 34.993.4 ± 48.20.597 TCFA, n (%)29 (37.7)12 (46.2)0.444Disruption, n (%)4 (3.0)5 (9.6)0.057Calcification, n (%)42 (31.1)15 (28.8)0.763Macrophage, n (%)42 (31.1)17 (32.7)0.835Microvessels (MC), n (%)50 (37.0)27 (51.9)0.064Cholesterol crystal, n (%)12 (8.9)5 (9.6)0.670Thrombus, n (%)2 (1.5)3 (5.7)0.103*Abbreviations: FCT* fibrous cap thickness, *IQR* interquartile range, *MLA* minimum lumen area, *RVA* reference vessel area, *SD* standard deviation, *TCFA* thin-cap fibroatheroma. Data are n (%) or mean ± SD

Univariate and multivariate linear regression models for Liped index {#Sec11}
--------------------------------------------------------------------

Table [4](#Tab4){ref-type="table"} shows the univariate and multivariate linear regression models. In the univariate model, sex and current smoker were all associated with a larger lipid index. Age, use of statin and aspirin were all associated with a smaller lipid index. The multivariate linear regression model demonstrated that only use of statin were an associated factor for a smaller lipid index after adjustment for other factors.Table 4Univariate and Multivariate Linear Regression Models for Lipid IndexUnivariate ModelMultivariate Modelβ Coefficient*P* Valueβ Coefficient*P* ValueAge−21.0120.004−2.8790.772Sex375.8670.037266.5590.259Hypertension83.1880.626158.8270.397Dyslipidemia221.8200.458552.9270.097Current smoker469.7480.014163.0040.474Diabetes mellitus304.6680.070230.1570.171Statins− 644.8890.000− 783.1990.023β-Blockers−226.4890.1719.5940.961Aspirin−510.2370.014307.2450.447TC−0.3830.855−0.6880.889LDL-C3.4530.2001.7540.769HDL-C−0.1030.9914.5010.659TG−0.7430.142−0.6170.486*Abbreviations: HDL-C* high-density lipoprotein cholesterol, *LDL-C* low-density lipoprotein cholesterol, *TC* total cholesterol, *TG* triglycerides. *P* values are from the inference using the generalized estimating equation--based sandwich SE estimates

Discussion {#Sec12}
==========

This OCT study focused on patients with CAD, and assessed gender differences in the characteristics of nonculprit plaques. We demonstrated that nonculprit plaques had reduced lipid index in female patients with CAD compared with male patients. The univariate linear regression model demonstrated that sex and current smoker were all associated with a larger LI, whereas in multivariate model only use of statin was independent risk factor for a larger LI.

At the time of presentation with CAD, women tend to be 10 years older than men \[[@CR28]\]. Consistent with previously reported data, the present study found that women were significantly older when presenting with suspected CAD than men, with average ages of 70.8 and 60.8 years in women and men, respectively. It has been reported that the burden of coronary plaque increases with age \[[@CR29]\], consistent with this result, univariate regression analysis in this study showed that age was positively correlated with LI. Even so, in present study, the LI of nonculprit plaques in man was still greater than that of plaque in female. In the present study, the active smoking rate of different gender patients was also different. The rate of current smokers in male patients was significantly higher than that of female patients. Previous angiographic and OCT studies shown that active smoking could increasing lipid accumulation \[[@CR30], [@CR31]\]. Our univariate regression analysis also showed that smoking was associated with greater LI, however, multivariate regression analysis showed that neither smoking nor gender was independent factor for LI. Therefore, smoking might contribute in part to the difference in nonculprit plaques between different genders.

Pathological studies have previously revealed differences in plaque morphologies between men and women \[[@CR32]--[@CR34]\]. A previous report demonstrated that among patients with ACS, women have less extensive coronary artery disease, by both angiographic and intravascular ultrasound (IVUS) measures, with lesions in women having less plaque rupture, reduced necrotic core and calcium, similar plaque burden, and smaller lumens compared with male patients, despite having more comorbid risk factors \[[@CR35]\]. In this study, the LDL levels in female patients were significantly higher than those in male patients, however, the LI of female patients was smaller. Monique et al. \[[@CR36]\] also used IVUS and near-infrared spectroscopy (NIRS) in CAD patients, and demonstrated that women have more favorable plaque characteristics than man, despite their worse risk profile.

On the other hand, several imaging studies have reported undifferentiated data regarding the relationship between gender and plaque characteristics. In patients with stable CAD, a multimodality intravascular imaging study observed no sex-specific differences in plaque morphology, as measured by lipid content, thin-cap fibroatheroma, calcification, microvessels, and macrophages in men and women \[[@CR37]\]. Additionally, in patients with ACS, a previous study found no gender differences in the number of plaques with disruption, calcification, or thrombus \[[@CR38]\]. Similarly, our team recently found that in patients with a first ST-segment elevation myocardial infarction (STEM), there are no differences in culprit plaque features between women and men \[[@CR39]\]. In this study, nonculprit lesions in women with suspected CAD exhibited shorter lipid-cores and smaller LI compared with male counterparts. However, this did not translate into differences in fibrous cap thickness and TCFA frequency between genders. Whether this reflects differential effects of risk factor exposure on the artery wall in women requires further investigation. Gender-related differences were not observed in cholesterol crystals and calcification within nonculprit plaques in this study. The current findings are consistent with those of previous OCT studies \[[@CR40]\] and complete previous reports assessing plaque features by OCT in CAD patients \[[@CR39], [@CR41]\].

The total number of deaths from cardiovascular diseases (CVD) is greater in women compared with men \[[@CR28], [@CR42]\]. However, OCT Imaging studies showed that plaque morphology in female CAD patients is not different from that of men, or even more stable compared with male plaques \[[@CR39], [@CR41], [@CR42]\]. The reasons for gender-related differences in clinical outcomes remain unclear. A possible reason for higher mortality and morbidity in women might be the higher burden of risk factors compared with men, including higher prevalence rates of risk factors not included in traditional risk-estimation algorithms, such as depression, physical inactivity, and a family history of premature CAD \[[@CR43]\]. Indeed, women are more affected by anxiety and depression than men \[[@CR28]\], which may explain worse recovery in women, to a certain extent. Notably, the Women's Ischemia Syndrome Evaluation study highlighted the importance of non-obstructive coronary artery disease, such as ischemia caused by microvascular disease, which is more commonly found in women compared with men \[[@CR2], [@CR44]\]. This phenomenon may partly explain why women have more favorable plaque characteristics, including reduced IL in nonculprit lesions, but show worse clinical outcomes. Long-term follow-up studies are required to comprehensively evaluate the clinical consequences of these differences.

Study limitations {#Sec13}
-----------------

The limitations of the present study should be noted. First, this was a retrospective observational study from a database; therefore, selection bias may have influenced the above results. Secondly, adjustment for potential confounding factors was not performed because of the limited sample size. Thirdly, the study design had an intrinsic limitation related to the imbalance between women and men in the general population. Nonetheless, this imbalance reflects the true distribution of patients with CAD.

Conclusions {#Sec14}
===========

In summary, nonculprit plaques contain reduced lipid cores in female patients with CAD compared with male counterparts. These findings highlight distinct pathophysiological features for atherosclerosis between genders, potentially leading to clinical presentation differences.
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